Abstract
Maximum duration of bronchodilator efficacy in inhaled liposome-based formulations depends on optimizing the in vivo release rate of the encapsulated bronchodilator. We investigated the effect of several formulation variables on the pulmonary residence time of 3H-terbutaline sulfate liposomes administered intratracheally in guinea pigs, using an improved method enabling the measurement of pulmonary drug absorption for extended periods of time in conscious animals. Half-lives of liposome-encapsulated 3H-terbutaline disappearance from the lungs and airways after instillation ranged from 1.4 to 18 hr and were markedly affected by liposome size, cholesterol content, and phospholipid composition. This study demonstrates that liposomes can significantly prolong the residence time of bronchodilators in the lungs and that precise control over the pulmonary residence time of encapsulated bronchodilators can be achieved by controlling formulation variables.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
P. J. Mihalko, H. Schreier, and R. M. Abra. Liposomes: A pulmonary perspective. In G. Gregoriadis (ed.), Liposomes as Drug Carriers, John Wiley & Sons, New York, 1988, pp. 679–694.
I. W. Kellaway and S. J. Farr. Liposomes as drug delivery systems to the lung. Adv. Drug Deliv. Rev. 5:149–161 (1990).
P. R. Byron, R. E. Notari, and M. Huang. Pharmacokinetic predictions of optimum drug delivery rates from prodrugs designed for maximum duration. Int. J. Pharm. 1:219–231 (1978).
J. H. Senior. Fate and behavior of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:123–193 (1987).
S. G. Woolfrey, G. Taylor, I. W. Kellaway, and A. Smith. Pulmonary absorption of liposome-encapsulated 6-carboxyfluorescein. J. Control. Release 5:203–209 (1988).
Y. Sato, H. Kiwada, and Y. Kato. Effects of dose and vesicle size on the pharmacokinetics of liposomes. Chem. Pharm. Bull. 34:4244–4252 (1986).
S. J. Enna and L. S. Schanker. Absorption of drugs from the rat lung. Am. J. Physiol. 223:1227–1231 (1972).
R. M. Abra, P. J. Mihalko, and H. Schreier. The effect of lipid composition upon the encapsulation and in vitro leakage of metaproterenol sulfate from 0.2 μm diameter, extruded, multitamellar liposomes. J. Control. Release 14:71–78 (1990).
Å. Ryrfeldt and N. Bodin. The physiological disposition of ibuterol, terbutaline and isoproterenol after endotracheal instillation to rats. Xenobiotica 5:521–529 (1975).
Å. Ryrfeldt and E. Nilsson. Uptake and biotransformation of ibuterol and terbutaline in isolated perfused rat and guinea pig lungs. Biochem. Pharmacol. 27:301–305 (1978).
R. A. Brown, Jr., and L. S. Schanker. Absorption of aerosolized drugs from the rat lung. Drug Metab. Distrib. 11:355–360 (1983).
L. S. Schanker, E. W. Mitchell, and R. A. Brown. Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection. Drug Metab. Disp. 14:79–88 (1986).
J. D. Brain, D. E. Knudson, S. P. Sorokin, and M. A. Davis. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ. Res. 11:13–33 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fielding, R.M., Abra, R.M. Factors Affecting the Release Rate of Terbutaline from Liposome Formulations After Intratracheal Instillation in the Guinea Pig. Pharm Res 9, 220–223 (1992). https://doi.org/10.1023/A:1018989423909
Issue Date:
DOI: https://doi.org/10.1023/A:1018989423909